Ironwood Pharmaceuticals (IRWD) News Today $4.21 +0.10 (+2.43%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Ironwood Pharmaceuticals (NASDAQ:IRWD) Downgraded by StockNews.com to BuyNovember 16 at 1:19 AM | americanbankingnews.comARMISTICE CAPITAL, LLC Acquires Significant Stake in Ironwood Pharmaceuticals IncNovember 14 at 10:10 PM | gurufocus.comGSA Capital Partners LLP Increases Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)GSA Capital Partners LLP lifted its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 194.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 351,193 shares of the biotechnology comNovember 14 at 4:46 AM | marketbeat.comIronwood Pharmaceuticals to Participate in the Jefferies London Healthcare ConferenceNovember 13, 2024 | businesswire.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and three haveNovember 12, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Lowered to "Buy" Rating by StockNews.comStockNews.com lowered shares of Ironwood Pharmaceuticals from a "strong-buy" rating to a "buy" rating in a research note on Tuesday.November 12, 2024 | marketbeat.comIronwood Pharmaceuticals Reports Third Quarter 2024 Results and Recent Business PerformanceNovember 12, 2024 | americanbankingnews.comResearch Analysts Set Expectations for IRWD FY2024 EarningsNovember 11, 2024 | americanbankingnews.comWhat is Leerink Partnrs' Estimate for IRWD FY2024 Earnings?Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Analysts at Leerink Partnrs cut their FY2024 earnings estimates for Ironwood Pharmaceuticals in a research report issued to clients and investors on Thursday, November 7th. Leerink Partnrs analyst F. Khurshid now expects that the biotecNovember 11, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call TranscriptNovember 10, 2024 | msn.comRobeco Institutional Asset Management B.V. Increases Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Robeco Institutional Asset Management B.V. grew its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 1,293.6% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 380,960 shares of the biotechnology company's stock after buying an additNovember 10, 2024 | marketbeat.comPositive Outlook for Ironwood Pharmaceuticals: LINZESS Growth and Apraglutide Potential Drive Buy RatingNovember 8, 2024 | markets.businessinsider.comIronwood Pharmaceuticals Reports Q3 2024 PerformanceNovember 8, 2024 | markets.businessinsider.comIronwood Pharmaceuticals (NASDAQ:IRWD) Posts Earnings Results, Misses Estimates By $0.07 EPSIronwood Pharmaceuticals (NASDAQ:IRWD - Get Free Report) announced its quarterly earnings data on Thursday. The biotechnology company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.07). The firm had revenue of $91.60 million for the quarter, compared to analyst estimates of $91.22 million. Ironwood Pharmaceuticals had a net margin of 2.30% and a negative return on equity of 6.37%. The company's quarterly revenue was down 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.12 EPS.November 8, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call PresentationNovember 7, 2024 | seekingalpha.comIronwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Down - Time to Sell?Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap Down - Time to Sell?November 7, 2024 | marketbeat.comEarnings Preview: Ironwood PharmaceuticalsNovember 6, 2024 | benzinga.comIronwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To ExpectNovember 6, 2024 | finance.yahoo.comCraig-Hallum Sticks to Its Buy Rating for Ironwood Pharma (IRWD)November 5, 2024 | markets.businessinsider.comIronwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.comStockNews.com raised shares of Ironwood Pharmaceuticals from a "buy" rating to a "strong-buy" rating in a report on Monday.November 4, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Emerald Advisers LLCEmerald Advisers LLC lowered its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 41.9% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 456,770 shares of the biotechnology company's stock afterNovember 4, 2024 | marketbeat.comIronwood Pharmaceuticals (IRWD) Set to Announce Earnings on ThursdayIronwood Pharmaceuticals (NASDAQ:IRWD) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=639955)October 31, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% Higher - Time to Buy?Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 9.1% - What's Next?October 28, 2024 | marketbeat.comIronwood Pharmaceuticals Shares Rise 10% on Positive Results in Bowel Disease StudyOctober 28, 2024 | marketwatch.comIronwood Pharmaceuticals to Host Third Quarter 2024 Investor Update CallOctober 24, 2024 | finance.yahoo.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock, Guidance And ForecastOctober 22, 2024 | benzinga.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock, Short Interest ReportOctober 22, 2024 | benzinga.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.8% - What's Next?Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.8% - What's Next?October 21, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven analysts that are presently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and foOctober 18, 2024 | marketbeat.comZacks Research Research Analysts Decrease Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Stock analysts at Zacks Research lowered their FY2025 earnings per share estimates for Ironwood Pharmaceuticals in a research note issued to investors on Monday, October 14th. Zacks Research analyst R. Department now forecasts that theOctober 17, 2024 | marketbeat.comWedge Capital Management L L P NC Purchases Shares of 314,843 Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Wedge Capital Management L L P NC acquired a new stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 314,843 shares of the biotechnology compaOctober 17, 2024 | marketbeat.comIs Ironwood Pharmaceuticals, Inc. (IRWD) the Penny Stock with the Biggest Upside Potential According to Analysts?October 16, 2024 | msn.comQ1 2025 EPS Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Cut by AnalystIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Research analysts at Zacks Research decreased their Q1 2025 earnings estimates for Ironwood Pharmaceuticals in a note issued to investors on Monday, October 14th. Zacks Research analyst R. Department now forecasts that the biotechnologyOctober 16, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 5.1% - What's Next?Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 5.1% - Here's What HappenedOctober 15, 2024 | marketbeat.comIronwood Pharmaceuticals Inc (IRWD) Q2 2024 Earnings Call Highlights: Strong LINZESS Demand ...October 9, 2024 | finance.yahoo.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading 3.6% Higher - Here's WhyIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Up 3.6% - What's Next?October 9, 2024 | marketbeat.comBank of Montreal Can Sells 8,419,683 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Bank of Montreal Can decreased its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 98.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 94,564 shares of the biotechnology company's stock after sellingOctober 9, 2024 | marketbeat.comSquarepoint Ops LLC Has $688,000 Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Squarepoint Ops LLC reduced its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 62.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 105,566 shares of the biotechnology company's stock after selling 179,194 shareOctober 8, 2024 | marketbeat.comAQR Capital Management LLC Has $4.46 Million Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)AQR Capital Management LLC boosted its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 45.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 684,578 shares of the biotechnology company's stoOctober 6, 2024 | marketbeat.comAmerican Century Companies Inc. Trims Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)American Century Companies Inc. reduced its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 82.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 57,62October 4, 2024 | marketbeat.comIronwood Pharmaceuticals: Balancing Financial Flexibility Against Revenue Challenges and High DebtOctober 3, 2024 | markets.businessinsider.comIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 6%Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Up 6%October 2, 2024 | marketbeat.comMercer Global Advisors Inc. ADV Has $108,000 Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Mercer Global Advisors Inc. ADV lessened its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 93.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,603 shares of the biotechnology company's stoOctober 2, 2024 | marketbeat.comArmistice Capital LLC Has $50.86 Million Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Armistice Capital LLC grew its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 44.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,800,000 shares of the biotechnology companSeptember 26, 2024 | marketbeat.comIRWD Dec 2024 7.500 putSeptember 22, 2024 | ca.finance.yahoo.comPacer Advisors Inc. Increases Stock Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)Pacer Advisors Inc. increased its position in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 23.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 8,907,639 shares of the biotechnology company's stock after puSeptember 22, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Holdings Boosted by Renaissance Technologies LLCRenaissance Technologies LLC grew its holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) by 20.7% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,571,898 shares of the biotechnSeptember 18, 2024 | marketbeat.comIronwood Pharmaceuticals (NASDAQ:IRWD) Shares Down 4.2% Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 4.2%September 16, 2024 | marketbeat.comIronwood Pharmaceuticals, Inc. to Post FY2026 Earnings of $0.48 Per Share, Zacks Research Forecasts (NASDAQ:IRWD)Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD - Free Report) - Stock analysts at Zacks Research dropped their FY2026 earnings estimates for shares of Ironwood Pharmaceuticals in a research note issued on Tuesday, September 10th. Zacks Research analyst R. Department now anticipates that the biotechnSeptember 12, 2024 | marketbeat.com Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address 📉 Warning: Market Crash Predicted - Secure Your Savings (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%. Take these 4 steps to protect your retirement here >>> IRWD Media Mentions By Week IRWD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRWD News Sentiment▼0.380.56▲Average Medical News Sentiment IRWD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRWD Articles This Week▼164▲IRWD Articles Average Week Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IGM Biosciences News Cryoport News Zentalis Pharmaceuticals News Kura Oncology News Geron News Ligand Pharmaceuticals News MannKind News Celldex Therapeutics News Myriad Genetics News Dynavax Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IRWD) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ironwood Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRWD Stock Alerts